Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Curr Opin Chem Biol. 2023 Jun 21;76:102352. doi: 10.1016/j.cbpa.2023.102352

Chemical Biology Approaches to Uncovering Nuclear ROS Control

Junbing Zhang 1, Liron Bar-Peled 1,2
PMCID: PMC10524750  NIHMSID: NIHMS1905061  PMID: 37352605

Abstract

Heightened concentrations of reactive metabolites, including reactive oxygen species (ROS), can damage all macromolecules leading to the erosion of cellular fidelity. In this regard, the control of nuclear ROS levels is essential for cellular homeostasis, and dysregulation of nuclear ROS has been attributed to multiple pathologies and the mechanism of action of certain chemotherapies. How nuclear ROS is generated, detoxified and sensed is poorly understood, and stems in part, from a historical lack of tools that allow for its precise generation and detection. Here, we summarize the latest advances in chemical biology inspired approaches that have been developed to study nuclear ROS and highlight how these tools have led to major breakthroughs in understanding its regulation. The continued development and application of chemical biology approaches to understand nuclear ROS promises to unlock fundamental insights into human physiology and disease.

Introduction

Metabolic compartmentalization is an essential feature of eukaryotic cells, providing a mechanism for resource allocation, detoxification and control1. The compartmentalization of reactive metabolites, and in particular reactive oxygen species (ROS) is necessary for maintaining cellular homeostasis because these oxygen-based metabolites can severely damage all biological macromolecules resulting in their inactivation and eventual cell death2,3. Much of the pathology of ROS-based damage has been attributed to the function of these reactive metabolites in the nucleus, given this organelle’s role in directing cellular function and as repository for hereditary material that is passed down to subsequent generations. ROS-based damage of nucleic acids results in both a change in the genetic code (most notably through the generation of 8-oxo-7,8-Dihydroguanine, 8-OxoG) and the generation of single stranded DNA lesions that ultimately result in genotoxic stress and a blockade in cell growth4. Not surprisingly, high levels of nuclear ROS are thought to underly multiple human pathologies, like immune deficiency (chronic granulomatous disease5), neurodegeneration (cockayne syndrome6) and premature aging (Hutchinson-Gilford progeria7,8). In addition to its role in pathophysiology, increasing nuclear ROS and the resultant DNA damage is attributed to the mode of action of numerous chemotherapies and radiotherapy911. Despite its clear biological importance, surprisingly little is known about how nuclear ROS is generated, detoxified and sensed. Underlying this knowledge-gap has been the historical lack of tools to study nuclear ROS at a necessary level of precision and resolution. However, the last decade has seen a remarkable growth in a set of ROS-centric chemical biology approaches that enable the detection and generation of ROS. In this perspective, we highlight recent technological breakthroughs useful for studying nuclear ROS and the new biological concepts that are emerging their deployment.

Chemical genomic approaches to generate nuclear ROS.

The traditional approach to manipulate nuclear ROS levels involved use of millimolar concentrations of H2O212 or other ROS generators (e.g., paraquat13), leading to pleiotropic cellular effects that made it difficult, if not impossible, to discern how nuclear ROS specifically impacts cell biology. The recent development of designer ROS generating enzymes and their nuclear localization has resulted in the ability to produce a spectrum of ROS in a nucleus-specific manner.

Photosensitizers.

Photosensitizing enzymes take advantage of photochemistry which occurs when a fluorescent protein chromophore is excited and results in the generation of a highly reactive and short-lived singlet oxygen (1O2) or superoxide (O2)14. Photoinducible ROS was first discovered using green fluorescent protein (GFP)15 and multiple derivatives have been developed over the last several years including KillerRed16, KillerOrange17, SuperNova18, miniSOG19,20 and TagRFP21, which broaden the spectrum of ROS that can be generated. Because these photosenstizors are genetically encoded they can be localized to the nucleus and specific regions of chromatin using traditional cell biological tags. Using the KillerRed photosensitizoer, Li and colleagues have uncovered novel mechanisms by which singlet oxygen generated at telomeres damages DNA22,23. This has led them to discover that RNA methyltransferase TRDMT1 is recruited to sites of ROS-induced lesions and that methylation of RNA in DNA:RNA hybrids increases the affinity for RAD52 binding and induction of homologous recombination and DNA repair24.

ROS-generating metabolic enzymes.

The generation of different ROS as product/byproduct of metabolic reactions is commonplace1 and has been leveraged as a tool to study ROS biology. D-amino acid oxidases (DAAO) are peroxisome localized flavoproteins that convert D-amino acids to their imine form using FAD as an electron acceptor25. During re-oxidation of FAD by O2, H2O2 is generated as byproduct. Importantly, the levels of peroxide can be exquisitely controlled by manipulating the concentrations of D-amino acids. Much like photosensitizing enzymes, the location of DAAO can be easily directed with appropriate tags. By developing a cardiac specific DAAO, Michell and colleagues demonstrated that chronic cardiac generation of H2O2 induces dilated cardiomyopathy with significant systolic dysfunction, providing a powerful in vivo approach to dissect H2O2 signaling and damage26.

Monitoring Nuclear ROS levels: small molecule and genetically encoded probes.

Many fluorescent probes have been developed to detect the intracellular H2O2, superoxide and hydroxyl measurement including Hydrocyanines, Xanthene and 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA), respectively. While there has been much emphasis in measuring mitochondrial ROS levels by appending triphenylphosphine30 to target small molecules to this compartment, most of these probes are not specific to a particular compartment and provide, with some accuracy, a holistic view of the redox potential within a cell. The recent development of nuclei-targetable H2O2 fluorescent probes31 and genetically encoded ROS reporters has been a game-changer in the study of nuclear ROS, enabling its real time dissection in vitro and in vivo.

Small molecule probes for nuclear H2O2.

Work by Chang and colleagues has focused on using boronate scaffolds which are responsive to H2O2. By taking advantage of SNAP-tag technology, they have successfully localized the cell permeable H2O2 probes to nucleus by conjugating them to nuclear-localized SNAP-tag fusion proteins32. Building on these initial findings, the Chang group developed the next-generation of nuclear targeted H2O2 probes (Nuclear Peroxy Emerald 1, NucPE1) with increased sensitivity for nuclear H2O2 levels that is compatible in both mammalian cell lines and C.elegans. Using these probes they find that over-expression of Sirtuin2 was sufficient to decrease nuclear H2O2 levels in C. elegans models of aging33,34. Additionally, Yi and colleagues developed a ratiometric H2O2 fluorescent probe (NP1) based on a 1,8-naphthalimide scaffold that is targeted to the nucleus by linking a nuclear localization signal (NLS) to boric acid ester (pep-NP1), for nucleus-targeted H2O2 imaging35.

Genetically encoded nuclear ROS reporters.

Much like their ROS-generating counterparts, genetically encoded fluorescent reporters have transformed the reactive metabolism field by enabling a new level of understanding of the heterogeneity and dynamics of compartmentalized ROS levels. Two families of H2O2 reporters are currently in wide use, reduction–oxidation sensitive GFP (roGFPs)-based H2O2 reporters and the Hydrogen Peroxide (HyPer) reporter a fusion of circularly permutated fluorescent protein (cpYFP) and the OxyR domain from the E. coli14,36. roGFP and its analogs developed by Dick and colleauges were engineered by the introduction of two cysteine residues into the beta barrel surface of GFP enabling sensitivity to changes in redox level37. The oxidation of the introduced cysteines within roGFP results in a conformational change and an alteration in GFP excitation from 400nm to 490 nm, providing a mechanism to distinguish the relative levels of oxidation versus reduction of the reporter38. (2) The HyPer class of reporters, developed by Belousov and colleagues, leverages intramolecular disulfide bond formation within the DNA-binding domain OxyR which results in analogous excitation change in cpYFP upon oxidation39. Although early versions of HyPer reporters were marked by sensitivity to intracellular pH, the latest iteration of the reporter (HyPer7), has overcome pH sensitivity providing an excellent dynamic range for measurement of peroxide levels in compartments throughout the cell40. When paired with DAAO, the HyPer7 reporter has provided clear insights into how manipulation of mitochondrial H2O2 levels directly impact H2O2 levels in different organelles41,42.

Nuclear ROS Generation and Sensing.

The utility of any tool is its applicability to discover new biology. Here we provide two examples where chemical biology tools specifically designed for the study of ROS were instrumental in uncovering how nuclear ROS is controlled.

Mitochondria ROS production controls nuclear H2O2 levels.

The source of nuclear ROS remains controversial. To date, few studies have pinpointed a nucleus-specific process that results in heightened ROS levels. Lysine demethylase 1 (LSD1) is a flavin-containing amine oxidases which catalyzes amine oxidation by oxidative cleavage of the α-carbon bond of the substrate to form an imine intermediate, which in turn, is hydrolyzed to form an aldehyde and amine via a nonenzymatic process. Recent studies have suggested that nuclear LSD1 demethylates histone H3 using FAD as a cofactor which upon reoxidation by O2 leads to localized H2O2 and 8-OxoG generation48,49. Additionally, NOX4 and MICAL1 are thought to contribute to nuclear H2O2 levels, albeit through poorly defined mechanisms50,51. A leading hypothesis for the source of nuclear ROS is the mitochondria given its predominant role as a cellular ROS generator52,53. Adding experimental validity to this hypothesis, Gillespie and colleagues found that during hypoxia a cellular stress known to increase mitochondrial ROS, mitochondria cluster around the nucleus providing the correct proximity for transfer of H2O2 to the nucleus. This finding was borne out of a clever combination of nuclear localized roGFP and disruption of mitochondrial trafficking, providing one mechanism by which mitochondrial positioning impacts nuclear ROS levels54. In later studies, Riemer and colleagues demonstrated that disabling cytoplasmic peroxiredoxins PRDX1/2 was a requirement for a rise in nuclear H2O2 levels following heightened mitochondrial ROS production41 A key finding emerging from these studies is that for mitochondrial-based ROS to reach the nucleus there must be an inactivation of cytosolic antioxidant defense systems or the perinuclear mitochondrial localization, given the robust reductive capacity of the cytosol41,42. More studies are need to understand the precise mechanisms by which ROS is transferred from the mitochondria through the cytoplasm to the nucleus.

Nuclear ROS sensing.

To maintain homeostasis, cells have evolved metabolic sensing pathways that are activated by changes in particular metabolites and regulate corresponding metabolic circuits to counter a systemic imbalance55,56,57. Thus, it stands that nuclear ROS sensing pathways would be activated prior to the accrual of DNA damage and regulate pathways that directly contribute to the control of ROS. Recent studies have provided compelling evidence for this hypothesis, finding that bona-fide nuclear ROS sensors are embedded within canonical DNA-damage response (DDR) pathways. Accordingly, upon heightened ROS levels these sensors control pathways to squelch these ROS. Recently, Zhang et al. have discovered cysteine 408 in the DDR kinase CHK1 functions as a nuclear H2O2 sensor. When CHK1 is activated by nuclear ROS, it downregulates mitochondrial translation and corresponding nuclear H2O2 levels. By integrating cysteine-focused chemical proteomics and genome wide CRISPRi screening, they profiled the functional cysteine reactive targets of chemotherapies which are thought to mediate cytotoxicity by increasing ROS levels. This roadmap of chemotherapy ROS targets revealed both distinct and common protein targets of chemotherapy and revealed that CHK1•C408 was sensitive to nuclear H2O2 levels. By deploying a modified nitrosobenzoate based sulfinic acid probe (NO-BIO58), they discovered that nuclear H2O2 oxidizes CHK1•C408 to its sulfinic acid form, resulting a conformational change whereby the interaction between the CHK1 autoinhibitory and kinase domains are disrupted, leading to kinase activation. Interestingly, disruption of CHK1 signaling by either a clinical-grade inhibitor (MK-877659,60) or genetic disruption, increased nuclear H2O2 levels, suggesting that CHK1 not only is modified by nuclear H2O2 but may control a cellular network that regulates nuclear ROS levels. By comparing CHK1 substrates to their corresponding sensitivity in the CRISPRi screen, mitochondrial DNA binding protein SSBP1 was identified as a compelling candidate. CHK1 phosphorylates SSBP1 at S67 in a H2O2 dependent manner which results in the relocation of SSBP1 from the mitochondria to the cytosol. The localization of SSBP1 is directly responsible for nuclear H2O2 levels. When phosphorylated by CHK1, SSBP1 accumulates in the cytosol and is rendered inactive resulting in a decrease in mitochondrial translation, which is necessary to mediate nuclear ROS levels through ETC complex I. In addition, the CHK1-SSBP1 circuit controls nuclear H2O2 levels in response to treatment with multiple chemotherapies including cisplatin and arsenic trioxide. Intriguingly, SSBP1 levels were downregulated in ovarian cancer tumors with decreased platinum free intervals and following the onset of chemoresistance. Further depleting SSBP1, mediated resistance to cisplatin in a panel of ovarian cancer models. These results suggest that SSBP1 may function as a biomarker for a tumors responsiveness to chemotherapies which result in heightened levels of nuclear ROS, providing an exciting example of nuclear-to-mitochondria communication through ROS-based signaling61.

Summary.

The exploration of nuclear ROS levels is still in its infancy and dissecting the regulation of this compartmentalized metabolite promises to unlock significant underlying physiology in both normal and diseases states. This exploration will benefit tremendously from tool development that allows the field to both control and monitor nuclear ROS levels. Looking into the future, as redox proteomic6264 analysis of nuclear proteins sheds light on additional ROS-modified targets, the development of corresponding antibodies against these sites will be critical not only for validation will serve as a critical tool to easily monitor compartmentalized ROS. We envision that these ROSdirected antibodies will accelerate research in this field akin to how the development of phosphoantibodies have revolutionized the study of kinase signaling.

Table 1.

ROS-generating enzymes which can be targeted to nucleus.

Enzymes EX/Em ROS type Ref.
GFP 489/511 1O2 15
KillerRed 585/610 O2•− 16
KillerOrange 512/555 O2•− 17
SOPP 439/488(515) 1O2 27
SuperNova 579/610 1O2/ O2•− 18
SuperNova Green 440/510 O2•− 28
miniSOG 448/500 1O2 19,20
mKate2 588/633 1O2/ O2•− 29
TagRFP 555/584 1O2 21
DAAO N/A H2O2 25

Ex excitation wavelength, Em emission wavelength, ROS reactive oxygen species, Ref. references, GFP green fluorescent protein, SOPP singlet-oxygen photosensitizing protein, SOG single-oxygen generator, DAAO D-amino acid oxidase.

Table 2.

Probe and protein reporters for nuclear ROS measurement.

Probe/ Reporter EX /Em (nm) ROS type Ref.
SNAP-PG1/PG2 488/500–550 H2O2 32
NucPE1 505/530 H2O2 33
pep-NP1 353/403 or 551 H2O2 35
roGFP2- Orp1 390 or 480/510–530 H2O2 43
roGFP2- Tsa2 405 or 488/510 H2O2 38
roGFP2- Prx1 405–415 or 474–490/510–550 H2O2 44
roGFP2- Tpx1 400 or 475–490/510 H2O2 45
HyPer 420 or 500/516 H2O2 39
HyPer2 420 or 497/516 H2O2 46
HyPer3 420 or 500/516 H2O2 47
HyPer7 400 or 490/516 H2O2 40

SNAP-PG SNAP-Peroxy-Green, NucPE1 Nuclear Peroxy Emerald 1, roGFP reduction–oxidation sensitive GFP, HyPer Hydrogen Peroxide reporter.

Declaration of interests

We thank all members of the Bar-Peled Lab for helpful suggestions. We apologize to our colleagues in the field for not being able to cite important contributions due to space limitations. This work was supported by the Damon Runyon Cancer Research Foundation (62-20), the American Association for Cancer Research (19-20-45-BARP), and the American Cancer Society, the Melanoma Research Alliance, the Ludwig Cancer Center of Harvard Medical School, Lungevity, ALK Positive, V-Foundation, Mary Kay Foundation, Paula and Rodger Riney Foundation, and the NIH/NCI (1R21CA226082-01, R37CA260062). Competing interests L.B-P. is a founder, consultant and holds privately held equity in Scorpion Therapeutics. J.Z. declares no competing interests.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Competing interests

L.B-P. is a founder, consultant and holds privately held equity in Scorpion Therapeutics. J.Z. declares no competing interests.

References

  • 1.Bar-Peled L, and Kory N (2022). Principles and functions of metabolic compartmentalization. Nat Metab 4, 1232–1244. 10.1038/s42255-022-00645-2 10.1038/s42255-022-00645-2 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.DeLoache WC, and Dueber JE (2013). Compartmentalizing metabolic pathways in organelles. Nat Biotechnol 31, 320–321. 10.1038/nbt.2549nbt.2549 [pii]. [DOI] [PubMed] [Google Scholar]
  • 3.Go YM, and Jones DP (2008). Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 1780, 1273–1290. 10.1016/j.bbagen.2008.01.011 S0304–4165(08)00026–3 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ziech D, Franco R, Pappa A, and Panayiotidis MI (2011). Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res 711, 167–173. 10.1016/j.mrfmmm.2011.02.015 S0027–5107(11)00057–1 [pii]. [DOI] [PubMed] [Google Scholar]
  • 5.Nunoi H, Nakamura H, Nishimura T, and Matsukura M (2023). Recent topics and advanced therapies in chronic granulomatous disease. Hum Cell 36, 515–527. 10.1007/s13577-022-00846-7 10.1007/s13577-022-00846-7 [pii]. [DOI] [PubMed] [Google Scholar]
  • 6.Chao M-R, Rossner P, Haghdoost S, Jeng HA, and Hu C-W (2013). Nucleic Acid Oxidation in Human Health and Disease. Oxidative Medicine and Cellular Longevity 2013, 1–2. 10.1155/2013/368651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kubben N, Zhang W, Wang L, Voss TC, Yang J, Qu J, Liu G-H, and Misteli T (2016). Repression of the Antioxidant NRF2 Pathway in Premature Aging. Cell 165, 1361–1374. 10.1016/j.cell.2016.05.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kowalska M, Piekut T, Prendecki M, Sodel A, Kozubski W, and Dorszewska J (2020). Mitochondrial and Nuclear DNA Oxidative Damage in Physiological and Pathological Aging. DNA and Cell Biology 39, 1410–1420. 10.1089/dna.2019.5347. [DOI] [PubMed] [Google Scholar]
  • 9.Wang H, Jiang H, Van De Gucht M, and De Ridder M (2019). Hypoxic Radioresistance: Can ROS Be the Key to Overcome It? Cancers (Basel) 11. 10.3390/cancers11010112 112 cancers11010112 [pii] cancers-11–00112 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, and Liang X (2018). The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 37, 266. 10.1186/s13046-018-0909-x266 10.1186/s13046-018-0909-x [pii] 909 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, and Migliaccio A (2020). ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52, 192–203. 10.1038/s12276-020-0384-2 10.1038/s12276-020-0384-2 [pii] 384 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chio IIC, and Tuveson DA (2017). ROS in Cancer: The Burning Question. Trends Mol Med 23, 411–429. S1471–4914(17)30043–6 [pii] 10.1016/j.molmed.2017.03.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Reczek CR, Birsoy K, Kong H, Martinez-Reyes I, Wang T, Gao P, Sabatini DM, and Chandel NS (2017). A CRISPR screen identifies a pathway required for paraquat-induced cell death. Nat Chem Biol 13, 1274–1279. 10.1038/nchembio.2499 nchembio.2499 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smolyarova DD, Podgorny OV, Bilan DS, and Belousov VV (2021). A guide to genetically encoded tools for the study of H2O2. The FEBS Journal 289, 5382–5395. 10.1111/febs.16088. [DOI] [PubMed] [Google Scholar]
  • 15.Jimenez-Banzo A, Nonell S, Hofkens J, and Flors C (2008). Singlet oxygen photosensitization by EGFP and its chromophore HBDI. Biophys J 94, 168–172. S0006–3495(08)70775–6 [pii] 107128 [pii] 10.1529/biophysj.107.107128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Bulina ME, Chudakov DM, Britanova OV, Yanushevich YG, Staroverov DB, Chepurnykh TV, Merzlyak EM, Shkrob MA, Lukyanov S, and Lukyanov KA (2006). A genetically encoded photosensitizer. Nat Biotechnol 24, 95–99. nbt1175 [pii] 10.1038/nbt1175. [DOI] [PubMed] [Google Scholar]
  • 17.Sarkisyan KS, Zlobovskaya OA, Gorbachev DA, Bozhanova NG, Sharonov GV, Staroverov DB, Egorov ES, Ryabova AV, Solntsev KM, Mishin AS, and Lukyanov KA (2015). KillerOrange, a Genetically Encoded Photosensitizer Activated by Blue and Green Light. PLoS One 10, e0145287. 10.1371/journal.pone.0145287 e0145287 PONE-D-15–27043 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Takemoto K, Matsuda T, Sakai N, Fu D, Noda M, Uchiyama S, Kotera I, Arai Y, Horiuchi M, Fukui K, et al. (2013). SuperNova, a monomeric photosensitizing fluorescent protein for chromophore-assisted light inactivation. Sci Rep 3, 2629. 10.1038/srep02629 2629 srep02629 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shu X, Lev-Ram V, Deerinck TJ, Qi Y, Ramko EB, Davidson MW, Jin Y, Ellisman MH, and Tsien RY (2011). A genetically encoded tag for correlated light and electron microscopy of intact cells, tissues, and organisms. PLoS Biol 9, e1001041. 10.1371/journal.pbio.1001041 e1001041 PBIOLOGY-D-1001083 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ryumina AP, Serebrovskaya EO, Shirmanova MV, Snopova LB, Kuznetsova MM, Turchin IV, Ignatova NI, Klementieva NV, Fradkov AF, Shakhov BE, et al. (2013). Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim Biophys Acta 1830, 5059–5067. S03044165(13)00318–8 [pii] 10.1016/j.bbagen.2013.07.015. [DOI] [PubMed] [Google Scholar]
  • 21.Ragas X, Cooper LP, White JH, Nonell S, and Flors C (2011). Quantification of photosensitized singlet oxygen production by a fluorescent protein. Chemphyschem 12, 161–165. 10.1002/cphc.201000919. [DOI] [PubMed] [Google Scholar]
  • 22.Lan L, Nakajima S, Wei L, Sun L, Hsieh CL, Sobol RW, Bruchez M, Van Houten B, Yasui A, and Levine AS (2014). Novel method for site-specific induction of oxidative DNA damage reveals differences in recruitment of repair proteins to heterochromatin and euchromatin. Nucleic Acids Res 42, 2330–2345. 10.1093/nar/gkt1233 gkt1233 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Tan J, Duan M, Yadav T, Phoon L, Wang X, Zhang JM, Zou L, and Lan L (2020). An R-loopinitiated CSB-RAD52-POLD3 pathway suppresses ROS-induced telomeric DNA breaks. Nucleic Acids Res 48, 1285–1300. 10.1093/nar/gkz1114 5645001 [pii] gkz1114 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]; * By introducing oxidative DNA damage locally at telomeres using a fusion protein of KillerRed (KR) and TRF1, the authors identifed a R-loopinitiated CSB–RAD52–POLD3 pathway required for ROS-induced telomeric DNA damage repair.
  • 24.Chen H, Yang H, Zhu X, Yadav T, Ouyang J, Truesdell SS, Tan J, Wang Y, Duan M, Wei L, et al. (2020). m(5)C modification of mRNA serves a DNA damage code to promote homologous recombination. Nat Commun 11, 2834. 10.1038/s41467-020-16722-72834 10.1038/s41467-020-16722-7 [pii] 16722 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pollegioni L, Diederichs K, Molla G, Umhau S, Welte W, Ghisla S, and Pilone MS (2002). Yeast D-amino acid oxidase: structural basis of its catalytic properties. J Mol Biol 324, 535–546. S0022283602010628 [pii] 10.1016/s0022-2836(02)01062-8. [DOI] [PubMed] [Google Scholar]
  • 26.Steinhorn B, Sorrentino A, Badole S, Bogdanova Y, Belousov V, and Michel T (2018). Chemogenetic generation of hydrogen peroxide in the heart induces severe cardiac dysfunction. Nat Commun 9, 4044. 10.1038/s41467-018-06533-2 4044 10.1038/s41467-018-06533-2 [pii] 6533 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Westberg M, Holmegaard L, Pimenta FM, Etzerodt M, and Ogilby PR (2015). Rational design of an efficient, genetically encodable, protein-encased singlet oxygen photosensitizer. J Am Chem Soc 137, 1632–1642. 10.1021/ja511940j. [DOI] [PubMed] [Google Scholar]
  • 28.Riani YD, Matsuda T, Takemoto K, and Nagai T (2018). Green monomeric photosensitizing fluorescent protein for photo-inducible protein inactivation and cell ablation. BMC Biol 16, 50. 10.1186/s12915-018-0514-750 10.1186/s12915-018-0514-7 [pii] 514 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shcherbo D, Murphy CS, Ermakova GV, Solovieva EA, Chepurnykh TV, Shcheglov AS, Verkhusha VV, Pletnev VZ, Hazelwood KL, Roche PM, et al. (2009). Far-red fluorescent tags for protein imaging in living tissues. Biochem J 418, 567–574. 10.1042/BJ20081949 BJ20081949 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, Cheng G, Lopez M, and Kalyanaraman B (2017). Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. Chem Rev 117, 10043–10120. 10.1021/acs.chemrev.7b00042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wen Y, Huo F, and Yin C (2019). Organelle targetable fluorescent probes for hydrogen peroxide. Chinese Chemical Letters 30, 1834–1842. 10.1016/j.cclet.2019.07.006. [DOI] [Google Scholar]
  • 32.Srikun D, Albers AE, Nam CI, Iavarone AT, and Chang CJ (2010). Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling. J Am Chem Soc 132, 4455–4465. 10.1021/ja100117u. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dickinson BC, Tang Y, Chang Z, and Chang CJ (2011). A nuclear-localized fluorescent hydrogen peroxide probe for monitoring sirtuin-mediated oxidative stress responses in vivo. Chem Biol 18, 943–948. 10.1016/j.chembiol.2011.07.005 S1074–5521(11)00236–5 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]; ** This study develped a highly sensitive chemical probes (NucPE1) for nuclear H2O2 levels that is compatible in both mammalian cell lines and C.elegans.
  • 34.Stanicka J, Russell EG, Woolley JF, and Cotter TG (2015). NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells. J Biol Chem 290, 93489361. 10.1074/jbc.M113.510495 S0021–9258(20)44404–7 [pii] M113.510495 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Wen Y, Liu K, Yang H, Li Y, Lan H, Liu Y, Zhang X, and Yi T (2014). A Highly Sensitive Ratiometric Fluorescent Probe for the Detection of Cytoplasmic and Nuclear Hydrogen Peroxide. Analytical Chemistry 86, 9970–9976. 10.1021/ac502909c. [DOI] [PubMed] [Google Scholar]
  • 36.Erard M, Dupré-Crochet S, and Nüße O (2018). Biosensors for spatiotemporal detection of reactive oxygen species in cells and tissues. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 314, R667–R683. 10.1152/ajpregu.00140.2017. [DOI] [PubMed] [Google Scholar]
  • 37.Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, Tsien RY, and Remington SJ (2004). Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279, 13044–13053. S0021–9258(19)64252–3 [pii] 10.1074/jbc.M312846200. [DOI] [PubMed] [Google Scholar]
  • 38.Morgan B, Van Laer K, Owusu TN, Ezerina D, Pastor-Flores D, Amponsah PS, Tursch A, and Dick TP (2016). Real-time monitoring of basal H2O2 levels with peroxiredoxin-based probes. Nat Chem Biol 12, 437–443. 10.1038/nchembio.2067 nchembio.2067 [pii]. [DOI] [PubMed] [Google Scholar]; ** Using yeast as a platform, the authors developed two roGFP derived H2O2 probes, roGFP2-Tsa2ΔCR and roGFP2-Tsa2ΔCPΔCR, which can be used for real-time monitoring of basal H2O2 levels with subcellular resolution.
  • 39.Belousov VV, Fradkov AF, Lukyanov KA, Staroverov DB, Shakhbazov KS, Terskikh AV, and Lukyanov S (2006). Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nature Methods 3, 281–286. 10.1038/nmeth866. [DOI] [PubMed] [Google Scholar]
  • 40.Pak VV, Ezeriņa D, Lyublinskaya OG, Pedre B, Tyurin-Kuzmin PA, Mishina NM, Thauvin M, Young D, Wahni K, Martínez Gache SA, et al. (2020). Ultrasensitive Genetically Encoded Indicator for Hydrogen Peroxide Identifies Roles for the Oxidant in Cell Migration and Mitochondrial Function. Cell Metabolism 31, 642–653.e646. 10.1016/j.cmet.2020.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]; ** By engineering cpGFP into the ultrasensitive OxyR domain from Neisseria meningitidis, the authors developed a new generation of H2O2 reporter HyPer7, which is pH-stable, ultrafast, and ultrasensitive.
  • 41.Hoehne MN, Jacobs LJHC, Lapacz KJ, Calabrese G, Murschall LM, Marker T, Kaul H, Trifunovic A, Morgan B, Fricker M, et al. (2022). Spatial and temporal control of mitochondrial H2O2 release in intact human cells. The EMBO Journal 41. 10.15252/embj.2021109169. [DOI] [PMC free article] [PubMed] [Google Scholar]; ** By targeting the genetically encoded high‐affinity H2O2 sensor, HyPer7 to different locations, the authors investigated different modes of mitochondrial H2O2 release and found the its gradient formation is controlled by cytosolic peroxiredoxins.
  • 42.de Cubas L, Pak VV, Belousov VV, Ayté J, and Hidalgo E (2021). The Mitochondria-to-Cytosol H2O2 Gradient Is Caused by Peroxiredoxin-Dependent Cytosolic Scavenging. Antioxidants 10, 731. 10.3390/antiox10050731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gutscher M, Sobotta MC, Wabnitz GH, Ballikaya S, Meyer AJ, Samstag Y, and Dick TP (2009). Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J Biol Chem 284, 3153231540. 10.1074/jbc.M109.059246 S0021–9258(20)37898–4 [pii] M109.059246 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Calabrese G, Peker E, Amponsah PS, Hoehne MN, Riemer T, Mai M, Bienert GP, Deponte M, Morgan B, and Riemer J (2019). Hyperoxidation of mitochondrial peroxiredoxin limits H(2) O(2) -induced cell death in yeast. EMBO J 38, e101552. 10.15252/embj.2019101552 e101552 EMBJ2019101552 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Carmona M, de Cubas L, Bautista E, Moral-Blanch M, Medrano-Fernandez I, Sitia R, Boronat S, Ayte J, and Hidalgo E (2019). Monitoring cytosolic H(2)O(2) fluctuations arising from altered plasma membrane gradients or from mitochondrial activity. Nat Commun 10, 4526. 10.1038/s41467-01912475-04526 10.1038/s41467-019-12475-0 [pii] 12475 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Markvicheva KN, Bilan DS, Mishina NM, Gorokhovatsky AY, Vinokurov LM, Lukyanov S, and Belousov VV (2011). A genetically encoded sensor for H2O2 with expanded dynamic range. Bioorg Med Chem 19, 1079–1084. 10.1016/j.bmc.2010.07.014 S0968–0896(10)00657–7 [pii]. [DOI] [PubMed] [Google Scholar]
  • 47.Bilan DS, Pase L, Joosen L, Gorokhovatsky AY, Ermakova YG, Gadella TW, Grabher C, Schultz C, Lukyanov S, and Belousov VV (2013). HyPer-3: a genetically encoded H(2)O(2) probe with improved performance for ratiometric and fluorescence lifetime imaging. ACS Chem Biol 8, 535–542. 10.1021/cb300625g. [DOI] [PubMed] [Google Scholar]
  • 48.Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, and Casero RA (2004). Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119, 941–953. S0092867404011997 [pii] 10.1016/j.cell.2004.12.012. [DOI] [PubMed] [Google Scholar]
  • 49.Duquette ML, Kim J, Shi LZ, and Berns MW (2018). LSD1 mediated changes in the local redox environment during the DNA damage response. PLoS One 13, e0201907. 10.1371/journal.pone.0201907 e0201907 PONE-D-18-09313 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Matsushima S, Kuroda J, Ago T, Zhai P, Park JY, Xie LH, Tian B, and Sadoshima J (2013). Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res 112, 651–663. 10.1161/CIRCRESAHA.112.279760 CIRCRESAHA.112.279760 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Deng W, Wang Y, Zhao S, Zhang Y, Chen Y, Zhao X, Liu L, Sun S, Zhang L, Ye B, and Du J (2018). MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway. J Cell Mol Med 22, 3108–3118. 10.1111/jcmm.13588 JCMM13588 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Diebold L, and Chandel NS (2016). Mitochondrial ROS regulation of proliferating cells. Free Radic Biol Med 100, 86–93. S0891–5849(16)30218–0 [pii] 10.1016/j.freeradbiomed.2016.04.198. [DOI] [PubMed] [Google Scholar]
  • 53.Murphy MP (2009). How mitochondria produce reactive oxygen species. Biochem J 417, 1–13. 10.1042/BJ20081386 BJ20081386 [pii] bj4170001 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Al-Mehdi AB, Pastukh VM, Swiger BM, Reed DJ, Patel MR, Bardwell GC, Pastukh VV, Alexeyev MF, and Gillespie MN (2012). Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal 5, ra47. 10.1126/scisignal.2002712 5/231/ra47 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]; * Using nuclear localized roGFP, the authors found that hypoxia induced perinuclear clustering creates an oxidant-rich nuclear domain, providing one mechanism by which mitochondrial positioning impacts nuclear ROS levels.
  • 55.Liu GY, and Sabatini DM (2020). mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol 21, 183–203. 10.1038/s41580-019-0199-y 10.1038/s41580-019-0199-y [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kaelin WG Jr. (2022). Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer. J Clin Invest 132. 10.1172/JCI162480 e162480 162480 [pii]. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Garcia D, and Shaw RJ (2017). AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance. Mol Cell 66, 789–800. S1097–2765(17)30396–9 [pii] 10.1016/j.molcel.2017.05.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Lo Conte M, Lin J, Wilson MA, and Carroll KS (2015). A Chemical Approach for the Detection of Protein Sulfinylation. ACS Chemical Biology 10, 1825–1830. 10.1021/acschembio.5b00124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Daud AI, Ashworth MT, Strosberg J, Goldman JW, Mendelson D, Springett G, Venook AP, Loechner S, Rosen LS, Shanahan F, et al. (2015). Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors. J Clin Oncol 33, 1060–1066. 10.1200/JCO.2014.57.5027 JCO.2014.57.5027 [pii]. [DOI] [PubMed] [Google Scholar]
  • 60.Webster JA, Tibes R, Morris L, Blackford AL, Litzow M, Patnaik M, Rosner GL, Gojo I, Kinders R, Wang L, et al. (2017). Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leuk Res 61, 108–116. S01452126(17)30513–1 [pii] 10.1016/j.leukres.2017.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Zhang J, Simpson CM, Berner J, Chong HB, Fang J, Ordulu Z, Weiss-Sadan T, Possemato AP, Harry S, Takahashi M, et al. (2023). Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway. Cell. S0092–8674(23)00422–1 [pii] 10.1016/j.cell.2023.04.026. [DOI] [PMC free article] [PubMed] [Google Scholar]; ** By Integrating chemical proteomic and functional CRISPR screens, this study identifies a nucleus-to-mitochondria ROS sensing pathway-required to resolve nuclear H2O2 accumulation.
  • 62.Shi Y, and Carroll KS (2020). Activity-Based Sensing for Site-Specific Proteomic Analysis of Cysteine Oxidation. Acc Chem Res 53, 20–31. 10.1021/acs.accounts.9b00562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kisty EA, Falco JA, and Weerapana E (2023). Redox proteomics combined with proximity labeling enables monitoring of localized cysteine oxidation in cells. Cell Chem Biol 30, 321–336 e326. S2451–9456(23)00055–7 [pii] 10.1016/j.chembiol.2023.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Niphakis MJ, and Cravatt BF (2014). Enzyme inhibitor discovery by activity-based protein profiling. Annu Rev Biochem 83, 341–377. 10.1146/annurev-biochem-060713-035708. [DOI] [PubMed] [Google Scholar]

RESOURCES